Uncategorized

The Omnitida BioActive Injection Pen Kit offers a range of benefits for individuals seeking effective medical support for weight management:

• Clinically proven weight loss – Tirzepatide helps significantly reduce body weight by lowering appetite and food intake.
• Dual-receptor action – Activates both GLP-1 and GIP receptors, enhancing the body's natural satiety signals.
• Once-weekly dosing – Designed for convenient, long-acting use with just one injection per week.
• Appetite regulation – Promotes a lasting feeling of fullness after smaller meals, making it easier to maintain dietary changes.
• Flexible titration – Allows gradual dose increases for better tolerability and individualised treatment.
• User-friendly format – Pre-filled pens enable easy at-home use with no need for mixing or measuring.

When combined with healthy eating and physical activity, Omnitida can support long-term, sustainable weight loss.

As with most medications, some individuals may experience side effects while using Omnitida. The most commonly reported is nausea.

These effects are typically mild to moderate in nature and tend to subside as the body adjusts to treatment.

For a full list of possible side effects, including rare and uncommon reactions, please refer to the patient information leaflet provided in the kit. If you have any concerns, consult your healthcare professional.

• 1 pre-filled injection pen with the prescribed dose of tirzepatide
• 1 alcohol swab for skin preparation
• A patient information leaflet with full instructions for use, storage, and safety

Omnitida BioActive contains tirzepatide, an innovative medication that mimics two natural hormones in the body — GLP-1 and GIP. These hormones regulate appetite and blood sugar levels after eating.

By activating both receptors, Omnitida BioActive:

• Reduces hunger and cravings
• Enhances the feeling of fullness after smaller meals
• Supports sustained weight loss when used alongside a healthy lifestyle

Omnitida BioActive is intended for adults who require medical support in managing their weight. It may be suitable for people who:

• Have a BMI of 30 or above (obesity), or
• Have a BMI of 27 or above with weight-related conditions such as high blood pressure, high cholesterol, or sleep apnoea.

Omnitida BioActive should only be used under medical supervision and with a valid prescription.

Omnitida BioActive is administered as a subcutaneous injection once per week.

• Injection sites include the abdomen, thigh, or upper arm
• Rotate injection sites with each dose to avoid irritation
• It can be taken at any time of day, with or without food
• Always follow the instructions provided in the leaflet or by your healthcare professional

• Take the missed dose as soon as possible within 4 days (96 hours)
• If more than 4 days have passed, skip the missed dose and continue with your next dose as scheduled
• Never take two doses less than 3 days (72 hours) apart

If you are unsure, consult your healthcare provider before your next injection.

• In the refrigerator at 2°C to 8°C
• Do not freeze
• Protect from direct light
• Keep in the original packaging until use
• Keep out of reach of children

Do not use if the product has been frozen, damaged, or discoloured.

Results vary between individuals. Many users notice a reduction in appetite and changes in eating habits within the first few weeks.

Significant and sustained weight loss generally occurs gradually over several months, especially when combined with a healthy diet and regular exercise.

Consistency is key — follow your prescribed schedule and stay in contact with your healthcare provider for the best outcomes.